The Future of Tissue-Based Therapies

Source: Cell & Gene

Enzyvant's CEO, Rachelle Jacques, explains the company's lead asset, the roadmap for tissue-based therapies, and more.

This website uses cookies to ensure you get the best experience on our website. Learn more